Community/Retail

This Valentine’s Day, pharmacists can remind patients that they may not need to feel guilty when they indulge in a small piece of chocolate.

Tresiba is indicated to improve glycemic control in patients with diabetes.

Bebtelovimab gets Emergency Use Authorization to treat mild-to-moderate COVID-19 in adults and pediatric patients who are at high risk for progression to severe COVID-19.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses contributing factors leading to health care professionals experience of an erosion of trust in the medicine supply chain.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, discusses the future of ketamine and psychedelic medicines in the treatment of mental health and brain disorders.

New analysis shows the substitution would cut costs by $600 million in the United States annually.

American Heart Month is another example of the essential and valuable position that pharmacists hold in improving health care outcomes and optimizing patient-centered care.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how drug shortages are related to medicine quality issues.

Study shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.

Joint Complex supports joint function and lubrication, as well as tissue hydration.

Edoxaban (Savaysa) can reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, addresses how pharmacists can respond to questions patients may ask them about ketamine and other psychedelic treatments.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, explains how ketamine infusions work when administered in patients’ homes and what safety precautions would be taken by providers in this setting.

New composite pharmacy adherence measure is a major step in developing standard pharmacy performance measures focused on improving patient care.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

Many faculty members are adept at training and teaching pharmacists and pharmacy technicians how to perform physical exams and tests.

Taking appropriate doses of vitamins and minerals may aid in lowering the risk of cardiovascular disease.

Lack of immediate results, cultural barriers, and high costs lead many to gamble with their cardiovascular health, study results show.

Tralokinumab-ldrm is an interleukin-13 antagonist recently approved for the treatment of moderate-to-severe atopic dermatitis.

Sagely Naturals Pain Relief Cream combines CBD with powerful botanicals, peppermint, and menthol.

Pharmacists are taking advantage of new opportunities, but there remain many other opportunities yet to be seized.

The calculation instrument displayed good discrimination, with a C-index of 0.72, as well as good calibration, investigators say.

Data suggest that omicron-specific CD8-positive T cell responses were more than 80% cross-reactive with the CD8-positive T cell response to the original strain of the virus.

A product containing phosphoric acid as well as alcohol successfully neutralized all of the virus particles.

The use of a unique trimer to produce tier-2 neutralizing antibodies may help fight HIV.

Vazalore has been shown to cause fewer stomach-related adverse effects than traditional aspirin.

Pain from golfer's elbow may spread into the forearm and wrist.

Sutimlimab-jome is the only approved treatment for individuals with CAD and works by inhibiting the destruction of red blood cells.

The majority of study participants demonstrated improvement of infraorbital hollows through 1 year.

The agency has also approved the baclofen oral suspension for Azurity Pharmaceuticals to treat individuals with other spinal cord diseases or injuries.